MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
ADC Therapeutics SA (ADCT) Ownership - Who owns ADC Therapeutics SA?
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
Profile
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
348.75M
P/E Ratio
N/A
Total Cash
264.56M
Projected Growth
N/A
Total Debt
117.52M
Revenue
77.25M
Risk (Beta)
2.66
Dividend Yield
N/A
Total Cash/Share
2.35
Total Debt/Equity
N/A
Revenue/Share
0.72 USD as % of share price
Fundamentals
ADCT
Capitalization
349M
P/E Ratio
N/A
Risk (Beta)
2.66
Dividend Yield
N/A
Total Cash
265M
Total Cash/Share
2.35
Total Debt
118M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.72%
Revenue
77.2M
ROE
N/A
Book Value
-199.18M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9.75M
Current Ratio
4.93
Current Revenue Per Employee
71631.18
Dividends Per Share - Security
N/A
EBITDA
-115M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.56
Revenue To Assets
-49.02
Shares Held By Institutions
195M
Shares Outstanding - Current
112M
Total Liabilities
521M
Total Volume MTD
N/A
Value
N/A
Gain YTD
56.281
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADCT showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com